Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
about
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.Treatment results of glioblastoma during the last 30 years in a single instituteIdentification of key genes in glioblastoma-associated stromal cells using bioinformatics analysis.PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review.Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.Integrated Cox's model for predicting survival time of glioblastoma multiforme.Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.Impact on Radiation Dose and Volume V57 Gy of the Brain on Recurrence and Survival of Patients with Glioblastoma Multiformae.A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
P2860
Q33992432-FD5B60ED-D7A3-46EF-9822-70181512E4E0Q35686908-F591BBCF-CA70-457D-98BC-61A4D78F5203Q35869502-26766332-A253-48CA-A9D8-BBD7D652DCEDQ36954204-5239E7EE-23D1-486A-A73C-06F94193E5C8Q37656468-33C4B9DC-B7D7-4A62-A1EA-70F7B33F4B6DQ37672546-9A1DB2CE-CD16-4824-81C8-31001ACCA7FCQ38607859-A13B42D2-188C-4C77-B826-3F20108F456FQ38661119-28731AB7-4803-4B88-8B5F-2E1ED65A8C8EQ38762476-2524F052-522D-41F0-B7B1-A7ACDFD4D456Q38851894-68D91525-F20F-4593-BC93-4206738604EDQ38910832-2A4E62CA-0C82-4063-8655-1DD411E45536Q38978686-9A54AEB5-B5EE-4BB7-8A9C-7F6E9C89C18BQ46020447-9AA113F0-C914-4624-BAC4-90EA12CB14E0Q47864874-33E38F17-5093-4C72-A7B8-FC34D6DAE379Q53698804-2B868BE6-E213-4788-8720-F41F7117F1D2
P2860
Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@ast
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@en
type
label
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@ast
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@en
prefLabel
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@ast
Effect of pretreatment clinica ...... ts (SEER) population analysis.
@en
P2093
P2860
P356
P1476
Effect of pretreatment clinica ...... lts (SEER) population analysis
@en
P2093
Alexander R Mackay
Ameer L Elaimy
Barton S Cooke
John J Demakas
Peter W Hanson
Robert K Fairbanks
Sudheer R Thumma
Wayne T Lamoreaux
P2860
P2888
P356
10.1186/1477-7819-10-75
P577
2012-05-03T00:00:00Z
P5875
P6179
1018609207